Point-of-Care Coagulation (POCC) Testing Devices Market Revenue Expansion and Industry Growth Analysis 2034
The global point-of-care coagulation (POCC) testing devices market growth in 2026 is gaining momentum as healthcare providers increasingly require rapid and accurate solutions for monitoring blood coagulation. Point-of-care coagulation testing enables clinicians to evaluate a patient's coagulation status in real time and supports timely clinical decisions across different healthcare settings. These devices are particularly important for monitoring patients with bleeding disorders and those receiving anticoagulation therapy during invasive or operative procedures.
According to Fortune Business Insights, the global point-of-care coagulation (POCC) testing devices market size was valued at USD 2.01 billion in 2025 and is projected to grow from USD 2.16 billion in 2026 to USD 3.88 billion by 2034, exhibiting a CAGR of 7.62% during the forecast period. North America dominated the market with a 42.38% share in 2025.
POCC testing devices are used for rapid assessment of hemostatic function during preoperative and postoperative care. They support coagulation monitoring in conditions such as hemophilia and venous thromboembolism and are also used for patients receiving low, moderate, or intensive anticoagulation. The growing need for rapid testing, technological advancements, home-based monitoring, and expanding healthcare infrastructure are contributing to market development.
Growing Need for Rapid Coagulation Monitoring Supports Market Expansion
The increasing patient population with bleeding disorders is an important factor supporting the demand for POCC testing devices. The market report highlights hemophilia, venous thromboembolism, and other bleeding disorders as conditions contributing to the need for coagulation monitoring. The growing geriatric population also generates demand for portable and easy-to-use testing devices because changes in hemostatic balance can occur with increasing age.
Severe bleeding can occur following trauma and during surgical procedures, creating a need for rapid assessment of hemostasis. Point-of-care testing provides fast results that can support coagulation management and guide the use of coagulation algorithms. These advantages are contributing to the adoption of POCC testing devices across healthcare environments.
Technological Advancements and Homecare Adoption Create New Growth Opportunities
Technological development is an important component of the point-of-care coagulation testing devices market. Companies are introducing devices designed to be easier to operate and more suitable for healthcare facilities and homecare environments. The development of connected devices has also enabled coagulation parameters, including prothrombin time and international normalized ratio, to be monitored through smartphones and digital platforms.
The growing focus on home healthcare is another factor shaping the market. Patients managing chronic bleeding disorders increasingly seek solutions that can reduce the need for frequent visits to healthcare facilities. Portable testing devices designed for independent monitoring are therefore gaining attention. Cloud-based solutions can also enable real-time data sharing between patients and healthcare providers and support remote anticoagulation management.
Market Drivers & Restraints:
Market Drivers:
Increasing patient population with bleeding disorders is supporting demand for coagulation monitoring.
Technological advancements are improving the usability and functionality of POCC testing devices.
Growing demand for home healthcare solutions is encouraging the development of portable and patient-friendly devices.
Improvement in healthcare infrastructure in emerging markets is creating opportunities for point-of-care testing.
Growing adoption of self-monitoring and connected coagulation testing devices is supporting market expansion.
Market Restraints:
High device costs can restrict adoption in emerging countries.
Additional battery and maintenance expenses can increase the overall cost of POCC testing.
Limited reimbursement policies can affect the adoption of home-based coagulation testing.
Stringent government regulations can create challenges for market expansion.
Traditional laboratory testing remains established across several clinical settings.
Top Companies In The Market
Werfen (Spain), Helena Laboratories Corporation (U.S.), Medtronic (Ireland), Abbott (U.S.), Hoffmann-La Roche Ltd (Switzerland), Siemens Healthcare AG (U.S.), Koninklijke Philips N.V. (Netherlands), HemoSonics, LLC (U.S.), Haemonetics Corporation (U.S.), and i-SENS, Inc. (South Korea).
Market Segments:
By Device Type (Anticoagulation Monitoring Devices {Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices, Activated Clotting Time (ACT), and Activated Partial Thromboplastin Time (aPPT)}, Platelet Function Monitoring Devices, Viscoelastic Coagulation Monitoring Devices {Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM)}, and Others)
By End User (Hospitals & Clinics, Homecare Settings, and Others)
Explore the full research report with detailed insights and TOC: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-coagulation-testing-devices-market-101235
Market Regional Insights:
North America: The region dominated the market with a 42.38% share in 2025 and generated USD 0.85 billion in 2025. The market is projected to reach USD 0.92 billion in 2026. The U.S. market is projected to reach USD 0.87 billion in 2026.
Asia Pacific: The market was valued at USD 0.41 billion in 2025 and is estimated to reach USD 0.45 billion in 2026. Rising numbers of patients with bleeding disorders and expanding company presence in emerging countries are supporting regional growth.
Europe: The market accounted for USD 0.56 billion in 2025 and is projected to reach USD 0.60 billion in 2026. Germany and the U.K. are among the regional markets highlighted in the report.
Future Market Scope:
The future scope of the point-of-care coagulation (POCC) testing devices market is closely associated with technological development, home-based testing, self-monitoring, and expansion into emerging markets. The increasing integration of devices with smartphones, cloud platforms, and electronic health records can support real-time data sharing and remote monitoring. Market participants are also focusing on portable and user-friendly systems that can be used outside conventional healthcare facilities.
Uncover Japan’s Market Trends - Explore the Latest -Point-of-Care Coagulation Testing Devices Market- Insights
Comments